Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$174.71
0.950.55%
At close: -
$174.82
0.110.07%
After Hours: May 16, 5:17 PM EDT
Comments
Loading...
Nutex Health Analyst Ratings and Price Targets | NASDAQ:NUTX | Benzinga
Nutex Health Inc has a consensus price target of $200 based on the ratings of 2 analysts. The high is $300 issued by Benchmark on May 15, 2025. The low is $100 issued by Maxim Group on April 8, 2025. The 3 most-recent analyst ratings were released by Benchmark, Maxim Group, and Maxim Group on May 15, 2025, April 8, 2025, and February 13, 2025, respectively. With an average price target of $158.33 between Benchmark, Maxim Group, and Maxim Group, there's an implied -9.43% downside for Nutex Health Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Benchmark
Maxim Group
1calculated from analyst ratings
Analyst Ratings for Nutex Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2025 | Buy Now | 71.6% | Benchmark | Bill Sutherland67% | $150 → $300 | Maintains | Buy | Get Alert |
| 04/08/2025 | Buy Now | -42.8% | Maxim Group | Anthony Vendetti63% | $75 → $100 | Maintains | Buy | Get Alert |
| 02/13/2025 | Buy Now | -57.1% | Maxim Group | Anthony Vendetti63% | $50 → $75 | Maintains | Buy | Get Alert |
| 11/12/2024 | Buy Now | -71.4% | Maxim Group | Anthony Vendetti63% | $45 → $50 | Maintains | Buy | Get Alert |
| 11/12/2024 | Buy Now | -65.68% | Benchmark | Bill Sutherland67% | $45 → $60 | Maintains | Buy | Get Alert |
| 09/18/2024 | Buy Now | -74.26% | Maxim Group | Anthony Vendetti63% | → $45 | Initiates | → Buy | Get Alert |
| 08/21/2024 | Buy Now | -74.26% | Benchmark | Bill Sutherland67% | $30 → $45 | Maintains | Buy | Get Alert |
| 01/25/2024 | Buy Now | -99.43% | Benchmark | Bill Sutherland67% | $1.5 → $1 | Maintains | Buy | Get Alert |
| 11/14/2023 | Buy Now | -99.14% | Benchmark | Bill Sutherland67% | $2.5 → $1.5 | Maintains | Buy | Get Alert |
| 08/29/2023 | Buy Now | -98.57% | Benchmark | Bill Sutherland67% | → $2.5 | Reiterates | Buy → Buy | Get Alert |
| 05/17/2023 | Buy Now | -98.57% | Benchmark | Bill Sutherland67% | $3 → $2.5 | Maintains | Buy | Get Alert |
| 03/09/2023 | Buy Now | -98.28% | Benchmark | Bill Sutherland67% | → $3 | Reiterates | → Buy | Get Alert |
| 12/23/2022 | Buy Now | -98.28% | Benchmark | Bill Sutherland67% | → $3 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Nutex Health (NUTX) stock?
The latest price target for Nutex Health (NASDAQ:NUTX) was reported by Benchmark on May 15, 2025. The analyst firm set a price target for $300.00 expecting NUTX to rise to within 12 months (a possible 71.60% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Nutex Health (NUTX)?
The latest analyst rating for Nutex Health (NASDAQ:NUTX) was provided by Benchmark, and Nutex Health maintained their buy rating.
When was the last upgrade for Nutex Health (NUTX)?
There is no last upgrade for Nutex Health
When was the last downgrade for Nutex Health (NUTX)?
There is no last downgrade for Nutex Health.
When is the next analyst rating going to be posted or updated for Nutex Health (NUTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nutex Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nutex Health was filed on May 15, 2025 so you should expect the next rating to be made available sometime around May 15, 2026.
Is the Analyst Rating Nutex Health (NUTX) correct?
While ratings are subjective and will change, the latest Nutex Health (NUTX) rating was a maintained with a price target of $150.00 to $300.00. The current price Nutex Health (NUTX) is trading at is $174.83, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
